Notch signaling pathway suppresses CD8+ T cells activity in patients with lung adenocarcinoma
Evolution and progression of cancer always leads to CD8+ T cells dysfunction/exhaustion. Controversy remains as to the role of Notch signaling pathway in CD8+ T cells regulation in tumorigenesis. Thus, the aim of this study was to investigate the immunomodulatory activity of Notch signaling pathway...
Gespeichert in:
Veröffentlicht in: | International immunopharmacology 2018-10, Vol.63, p.129-136 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 136 |
---|---|
container_issue | |
container_start_page | 129 |
container_title | International immunopharmacology |
container_volume | 63 |
creator | Li, Shuo Wang, Zhe Li, Xin-Ju |
description | Evolution and progression of cancer always leads to CD8+ T cells dysfunction/exhaustion. Controversy remains as to the role of Notch signaling pathway in CD8+ T cells regulation in tumorigenesis. Thus, the aim of this study was to investigate the immunomodulatory activity of Notch signaling pathway to peripheral and lung-resident CD8+ T cells in patients with lung adenocarcinoma. Forty-eight lung adenocarcinoma patients and twenty healthy individuals were enrolled in the current study, and CD8+ T cells were purified from both peripheral bloods and bronchoalveolar lavage fluids. Notch receptor mRNA expression was semi-quantified by real-time PCR. Cytolytic and noncytolytic activity of CD8+ T cells evaluated in direct and indirect contact co-culture with A549 cells in response to Notch signaling inhibition by measuring of lactate dehydrogenase release and cytokines production. Expression of Fas ligand (FasL), perforin, and granzyme B were also assessed by flow cytometry. Notch2 mRNA expression was elevated in both peripheral and lung-resident CD8+ T cells in lung adenocarcinoma patients, however, did not correlated with tumor stages or epidermal growth factor receptor mutation. Peripheral CD8+ T cells from healthy individuals exhibited stronger cytotoxicity in direct contact co-culture system, which was not influenced by Notch signaling inhibition. Moreover, suppression of Notch signaling augmented cytotoxicity of peripheral and lung-resident CD8+ T cells from lung adenocarcinoma patients in direct contact co-culture system, and promoted interferon-γ production in both systems. This process was accompanied by increased expression of FasL and perforin within CD8+ T cells. The current data revealed a potential immunosuppressive property of Notch signaling pathway to CD8+ T cells probably via inhibition of FasL and perforin in lung adenocarcinoma patients.
•Notch2 was highly expressed in CD8+ T cells in lung adenocarcinoma patients.•CD8+ T cells was dysfunctional in lung adenocarcinoma patients.•Notch signaling inhibited cytolytic and noncytolytic function of CD8+ T cells.•Notch signaling suppressed FasL and perforin expression in CD8+ T cells. |
doi_str_mv | 10.1016/j.intimp.2018.07.033 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2085655652</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S156757691830362X</els_id><sourcerecordid>2085655652</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-88cdc2ae38839f0fb6dadb888e306b5306549899716f51f633152c3fff2400373</originalsourceid><addsrcrecordid>eNp9kF1LBCEUhiWKvv9BhJdBzHQcV8e5CWL7hKib7TLEdbR1ma_U2dh_n8tWl4GoyPN6znkQOiOQEyD8apm7Lrp2yAsgIocyB0p30CERpchICWw33RkvM1by6gAdhbAESO8Tso8OKIDgjLJD9P7SR73AwX10qnHdBx5UXHypNQ7jMHgTggl4eisu8Qxr0zQBKx3dysU1dt2GdaaLAX-5uMDNmOKqNl2vldeu61t1gvasaoI5_TmP0dv93Wz6mD2_PjxNb54zTXkRMyF0rQtlqBC0smDnvFb1XAhhKPA5SxubVKKqSsItI5ZTSlihqbW2mADQkh6ji-2_g-8_RxOibF3Y9Ks6049BFiAYZ2kVCZ1sUe37ELyxcvCuVX4tCciNWLmUW7FyI1ZCKZPYFDv_qTDOW1P_hX5NJuB6C5g058oZL4NOcrSpnTc6yrp3_1f4BgIYi58</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2085655652</pqid></control><display><type>article</type><title>Notch signaling pathway suppresses CD8+ T cells activity in patients with lung adenocarcinoma</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Li, Shuo ; Wang, Zhe ; Li, Xin-Ju</creator><creatorcontrib>Li, Shuo ; Wang, Zhe ; Li, Xin-Ju</creatorcontrib><description>Evolution and progression of cancer always leads to CD8+ T cells dysfunction/exhaustion. Controversy remains as to the role of Notch signaling pathway in CD8+ T cells regulation in tumorigenesis. Thus, the aim of this study was to investigate the immunomodulatory activity of Notch signaling pathway to peripheral and lung-resident CD8+ T cells in patients with lung adenocarcinoma. Forty-eight lung adenocarcinoma patients and twenty healthy individuals were enrolled in the current study, and CD8+ T cells were purified from both peripheral bloods and bronchoalveolar lavage fluids. Notch receptor mRNA expression was semi-quantified by real-time PCR. Cytolytic and noncytolytic activity of CD8+ T cells evaluated in direct and indirect contact co-culture with A549 cells in response to Notch signaling inhibition by measuring of lactate dehydrogenase release and cytokines production. Expression of Fas ligand (FasL), perforin, and granzyme B were also assessed by flow cytometry. Notch2 mRNA expression was elevated in both peripheral and lung-resident CD8+ T cells in lung adenocarcinoma patients, however, did not correlated with tumor stages or epidermal growth factor receptor mutation. Peripheral CD8+ T cells from healthy individuals exhibited stronger cytotoxicity in direct contact co-culture system, which was not influenced by Notch signaling inhibition. Moreover, suppression of Notch signaling augmented cytotoxicity of peripheral and lung-resident CD8+ T cells from lung adenocarcinoma patients in direct contact co-culture system, and promoted interferon-γ production in both systems. This process was accompanied by increased expression of FasL and perforin within CD8+ T cells. The current data revealed a potential immunosuppressive property of Notch signaling pathway to CD8+ T cells probably via inhibition of FasL and perforin in lung adenocarcinoma patients.
•Notch2 was highly expressed in CD8+ T cells in lung adenocarcinoma patients.•CD8+ T cells was dysfunctional in lung adenocarcinoma patients.•Notch signaling inhibited cytolytic and noncytolytic function of CD8+ T cells.•Notch signaling suppressed FasL and perforin expression in CD8+ T cells.</description><identifier>ISSN: 1567-5769</identifier><identifier>EISSN: 1878-1705</identifier><identifier>DOI: 10.1016/j.intimp.2018.07.033</identifier><identifier>PMID: 30086535</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>A549 Cells ; Adenocarcinoma of Lung - genetics ; Adenocarcinoma of Lung - immunology ; Adult ; CD8+ T cells ; CD8-Positive T-Lymphocytes - immunology ; Coculture Techniques ; Fas Ligand Protein - immunology ; Female ; Humans ; Immunomodulation ; Lung adenocarcinoma ; Lung Neoplasms - genetics ; Lung Neoplasms - immunology ; Male ; Middle Aged ; Notch signaling ; Perforin - immunology ; Receptor, Notch1 - genetics ; Receptor, Notch1 - immunology ; Receptor, Notch2 - genetics ; Receptor, Notch2 - immunology ; Signal Transduction</subject><ispartof>International immunopharmacology, 2018-10, Vol.63, p.129-136</ispartof><rights>2018 Elsevier B.V.</rights><rights>Copyright © 2018 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-88cdc2ae38839f0fb6dadb888e306b5306549899716f51f633152c3fff2400373</citedby><cites>FETCH-LOGICAL-c362t-88cdc2ae38839f0fb6dadb888e306b5306549899716f51f633152c3fff2400373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.intimp.2018.07.033$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30086535$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Shuo</creatorcontrib><creatorcontrib>Wang, Zhe</creatorcontrib><creatorcontrib>Li, Xin-Ju</creatorcontrib><title>Notch signaling pathway suppresses CD8+ T cells activity in patients with lung adenocarcinoma</title><title>International immunopharmacology</title><addtitle>Int Immunopharmacol</addtitle><description>Evolution and progression of cancer always leads to CD8+ T cells dysfunction/exhaustion. Controversy remains as to the role of Notch signaling pathway in CD8+ T cells regulation in tumorigenesis. Thus, the aim of this study was to investigate the immunomodulatory activity of Notch signaling pathway to peripheral and lung-resident CD8+ T cells in patients with lung adenocarcinoma. Forty-eight lung adenocarcinoma patients and twenty healthy individuals were enrolled in the current study, and CD8+ T cells were purified from both peripheral bloods and bronchoalveolar lavage fluids. Notch receptor mRNA expression was semi-quantified by real-time PCR. Cytolytic and noncytolytic activity of CD8+ T cells evaluated in direct and indirect contact co-culture with A549 cells in response to Notch signaling inhibition by measuring of lactate dehydrogenase release and cytokines production. Expression of Fas ligand (FasL), perforin, and granzyme B were also assessed by flow cytometry. Notch2 mRNA expression was elevated in both peripheral and lung-resident CD8+ T cells in lung adenocarcinoma patients, however, did not correlated with tumor stages or epidermal growth factor receptor mutation. Peripheral CD8+ T cells from healthy individuals exhibited stronger cytotoxicity in direct contact co-culture system, which was not influenced by Notch signaling inhibition. Moreover, suppression of Notch signaling augmented cytotoxicity of peripheral and lung-resident CD8+ T cells from lung adenocarcinoma patients in direct contact co-culture system, and promoted interferon-γ production in both systems. This process was accompanied by increased expression of FasL and perforin within CD8+ T cells. The current data revealed a potential immunosuppressive property of Notch signaling pathway to CD8+ T cells probably via inhibition of FasL and perforin in lung adenocarcinoma patients.
•Notch2 was highly expressed in CD8+ T cells in lung adenocarcinoma patients.•CD8+ T cells was dysfunctional in lung adenocarcinoma patients.•Notch signaling inhibited cytolytic and noncytolytic function of CD8+ T cells.•Notch signaling suppressed FasL and perforin expression in CD8+ T cells.</description><subject>A549 Cells</subject><subject>Adenocarcinoma of Lung - genetics</subject><subject>Adenocarcinoma of Lung - immunology</subject><subject>Adult</subject><subject>CD8+ T cells</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Coculture Techniques</subject><subject>Fas Ligand Protein - immunology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunomodulation</subject><subject>Lung adenocarcinoma</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - immunology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Notch signaling</subject><subject>Perforin - immunology</subject><subject>Receptor, Notch1 - genetics</subject><subject>Receptor, Notch1 - immunology</subject><subject>Receptor, Notch2 - genetics</subject><subject>Receptor, Notch2 - immunology</subject><subject>Signal Transduction</subject><issn>1567-5769</issn><issn>1878-1705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1LBCEUhiWKvv9BhJdBzHQcV8e5CWL7hKib7TLEdbR1ma_U2dh_n8tWl4GoyPN6znkQOiOQEyD8apm7Lrp2yAsgIocyB0p30CERpchICWw33RkvM1by6gAdhbAESO8Tso8OKIDgjLJD9P7SR73AwX10qnHdBx5UXHypNQ7jMHgTggl4eisu8Qxr0zQBKx3dysU1dt2GdaaLAX-5uMDNmOKqNl2vldeu61t1gvasaoI5_TmP0dv93Wz6mD2_PjxNb54zTXkRMyF0rQtlqBC0smDnvFb1XAhhKPA5SxubVKKqSsItI5ZTSlihqbW2mADQkh6ji-2_g-8_RxOibF3Y9Ks6049BFiAYZ2kVCZ1sUe37ELyxcvCuVX4tCciNWLmUW7FyI1ZCKZPYFDv_qTDOW1P_hX5NJuB6C5g058oZL4NOcrSpnTc6yrp3_1f4BgIYi58</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Li, Shuo</creator><creator>Wang, Zhe</creator><creator>Li, Xin-Ju</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201810</creationdate><title>Notch signaling pathway suppresses CD8+ T cells activity in patients with lung adenocarcinoma</title><author>Li, Shuo ; Wang, Zhe ; Li, Xin-Ju</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-88cdc2ae38839f0fb6dadb888e306b5306549899716f51f633152c3fff2400373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>A549 Cells</topic><topic>Adenocarcinoma of Lung - genetics</topic><topic>Adenocarcinoma of Lung - immunology</topic><topic>Adult</topic><topic>CD8+ T cells</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Coculture Techniques</topic><topic>Fas Ligand Protein - immunology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunomodulation</topic><topic>Lung adenocarcinoma</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - immunology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Notch signaling</topic><topic>Perforin - immunology</topic><topic>Receptor, Notch1 - genetics</topic><topic>Receptor, Notch1 - immunology</topic><topic>Receptor, Notch2 - genetics</topic><topic>Receptor, Notch2 - immunology</topic><topic>Signal Transduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Shuo</creatorcontrib><creatorcontrib>Wang, Zhe</creatorcontrib><creatorcontrib>Li, Xin-Ju</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International immunopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Shuo</au><au>Wang, Zhe</au><au>Li, Xin-Ju</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Notch signaling pathway suppresses CD8+ T cells activity in patients with lung adenocarcinoma</atitle><jtitle>International immunopharmacology</jtitle><addtitle>Int Immunopharmacol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>63</volume><spage>129</spage><epage>136</epage><pages>129-136</pages><issn>1567-5769</issn><eissn>1878-1705</eissn><abstract>Evolution and progression of cancer always leads to CD8+ T cells dysfunction/exhaustion. Controversy remains as to the role of Notch signaling pathway in CD8+ T cells regulation in tumorigenesis. Thus, the aim of this study was to investigate the immunomodulatory activity of Notch signaling pathway to peripheral and lung-resident CD8+ T cells in patients with lung adenocarcinoma. Forty-eight lung adenocarcinoma patients and twenty healthy individuals were enrolled in the current study, and CD8+ T cells were purified from both peripheral bloods and bronchoalveolar lavage fluids. Notch receptor mRNA expression was semi-quantified by real-time PCR. Cytolytic and noncytolytic activity of CD8+ T cells evaluated in direct and indirect contact co-culture with A549 cells in response to Notch signaling inhibition by measuring of lactate dehydrogenase release and cytokines production. Expression of Fas ligand (FasL), perforin, and granzyme B were also assessed by flow cytometry. Notch2 mRNA expression was elevated in both peripheral and lung-resident CD8+ T cells in lung adenocarcinoma patients, however, did not correlated with tumor stages or epidermal growth factor receptor mutation. Peripheral CD8+ T cells from healthy individuals exhibited stronger cytotoxicity in direct contact co-culture system, which was not influenced by Notch signaling inhibition. Moreover, suppression of Notch signaling augmented cytotoxicity of peripheral and lung-resident CD8+ T cells from lung adenocarcinoma patients in direct contact co-culture system, and promoted interferon-γ production in both systems. This process was accompanied by increased expression of FasL and perforin within CD8+ T cells. The current data revealed a potential immunosuppressive property of Notch signaling pathway to CD8+ T cells probably via inhibition of FasL and perforin in lung adenocarcinoma patients.
•Notch2 was highly expressed in CD8+ T cells in lung adenocarcinoma patients.•CD8+ T cells was dysfunctional in lung adenocarcinoma patients.•Notch signaling inhibited cytolytic and noncytolytic function of CD8+ T cells.•Notch signaling suppressed FasL and perforin expression in CD8+ T cells.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>30086535</pmid><doi>10.1016/j.intimp.2018.07.033</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1567-5769 |
ispartof | International immunopharmacology, 2018-10, Vol.63, p.129-136 |
issn | 1567-5769 1878-1705 |
language | eng |
recordid | cdi_proquest_miscellaneous_2085655652 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | A549 Cells Adenocarcinoma of Lung - genetics Adenocarcinoma of Lung - immunology Adult CD8+ T cells CD8-Positive T-Lymphocytes - immunology Coculture Techniques Fas Ligand Protein - immunology Female Humans Immunomodulation Lung adenocarcinoma Lung Neoplasms - genetics Lung Neoplasms - immunology Male Middle Aged Notch signaling Perforin - immunology Receptor, Notch1 - genetics Receptor, Notch1 - immunology Receptor, Notch2 - genetics Receptor, Notch2 - immunology Signal Transduction |
title | Notch signaling pathway suppresses CD8+ T cells activity in patients with lung adenocarcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T07%3A29%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Notch%20signaling%20pathway%20suppresses%20CD8+%20T%20cells%20activity%20in%20patients%20with%20lung%20adenocarcinoma&rft.jtitle=International%20immunopharmacology&rft.au=Li,%20Shuo&rft.date=2018-10&rft.volume=63&rft.spage=129&rft.epage=136&rft.pages=129-136&rft.issn=1567-5769&rft.eissn=1878-1705&rft_id=info:doi/10.1016/j.intimp.2018.07.033&rft_dat=%3Cproquest_cross%3E2085655652%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2085655652&rft_id=info:pmid/30086535&rft_els_id=S156757691830362X&rfr_iscdi=true |